Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boehringer Ingelheim
With
Eli Lilly and Company
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Signed and dated written informed consent.
Male or female patients diagnosed with type 1 diabetes (T1D) at least 6 months prior to informed consent or type 2 diabetes (T2D) or non-diabetic obese patients.
T1D patients must use and be willing of and be willing to continue throughout the duration of the trial either:
multiple daily injections of insulin OR
continuous sub-cutaneous insulin infusion of any insulin type, with at least 3 months experience
For patients with T1D or T2D,HbA1c of 6.5 - 11%
Age at least 18 years of age
Body mass index of \>=18.5 kg/m\^2
Estimated glomerular filtration rate greater than or equal to 60 ml/min/1.73m2
Blood pressure greater than 90 /60 mmHg and less than or equal to 140 / 90 mmHg
Use of a highly effective method of contraception.
You may not be if
For patients with T1D, treatment with an antihyperglycaemic agent within 3 months prior to visit 1
occurrence of severe hypoglycaemia within 3 months prior to visit 1
hypoglycaemic unawareness within 3 months prior to visit 1
